SCHEMBL6709908

SCHEMBL6709908

CC(CC(=O)Nc1cccc2cc(C(=O)Nc3ccc(Br)cc3-c3noc(=O)[nH]3)[nH]c12)CC(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 1/20 0.36
MAPT P10636 4/20 0.34
MAPK1 P28482 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
PTK2B Q14289 2/20 0.34
PTK2 Q05397 1/20 0.34
MAP3K5 Q99683 1/20 0.34
HPGD P15428 2/20 0.33
RAB9A P51151 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
LMNA P02545 2/20 0.33
NPC1 O15118 1/20 0.33
HTT P42858 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
NSD2 O96028 1/20 0.33
TP53 P04637 1/20 0.32
POLB P06746 1/20 0.32
PLA2G7 Q13093 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6707917 0.91 GRIK1 (0.38) GRIK1MAPTMAPK1TDP1PTK2B
SCHEMBL6710057 0.91 GRIK1 (0.39) GRIK1MAPTMAPK1TDP1PTK2B
SCHEMBL6707738 0.89 GRIK1 (0.39) GRIK1MAPTMAPK1TDP1PTK2B
SCHEMBL6710359 0.89 PLA2G7 (0.34) MAPTMAPK1TDP1PTK2BPTK2
SCHEMBL6713262 0.87 GRIK1 (0.41) GRIK1MAPTMAPK1TDP1HPGD
SCHEMBL6711904 0.86 MAP3K5 (0.36) MAPTMAPK1TDP1PTK2BPTK2
SCHEMBL6711957 0.85 GRIK1 (0.40) GRIK1MAPTMAPK1TDP1HPGD
SCHEMBL6713519 0.85 GRIK1 (0.41) GRIK1MAPTMAPK1TDP1LMNA
SCHEMBL6707860 0.84 GRIK1 (0.39) GRIK1MAPTMAPK1TDP1LMNA
SCHEMBL6710107 0.84 GRIK1 (0.39) GRIK1MAPTMAPK1TDP1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 GRIK1 3885/4885MAPT 4754/4885MAPK1 2728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.